Nutrien Reports Record Earnings and an Excellent Outlook

Nutrien Ltd. (TSX and NYSE: NTR) announced today its second quarter 2021 results, with net earnings of $1.1 billion ($1.94 diluted earnings per share). Second-quarter adjusted net earnings¹ were $2.08 per share and adjusted EBITDA¹ was $2.2 billion.

"We delivered record earnings across our global business for the second quarter and first half of 2021 and expect the remainder of the year to contribute to a full year record. We showcased Nutrien's unique competitive advantages, strong operating performance and the significant leverage to higher fertilizer prices as we focus on our purpose to help growers meet the ever-growing demand for increased food production in a sustainable manner," commented Mayo Schmidt, Nutrien's President and CEO.

"The outlook for global crop and fertilizer markets continues to be very strong and we are positioned to benefit from our structural advantages and as a global leader in agriculture. We increased our full year 2021 adjusted EBITDA guidance¹ by over $1.5 billion, supported in part by our quick actions to produce an additional one million tonnes of potash, illustrating the power of the Potash team's unparalleled flexible, reliable, and low-cost six-mine network," added Mr. Schmidt.

Highlights:

• Nutrien generated record adjusted EBITDA of $3.0 billion and free cash flow¹ of $1.9 billion in the first half of 2021. This represents an increase of 36 percent and 40 percent, respectively, compared to the first half of 2020 and 17 percent and 12 percent, respectively higher than the previous record for the company in the first half of 2019.
• Nutrien raised full-year 2021 adjusted EBITDA and adjusted net earnings per share¹ guidance to $6.0 to $6.4 billion and $4.60 to $5.10 per share, respectively. This reflects higher expected results across our business, as well as, the benefits of increasing our 2021 potash sales guidance by one million tonnes to address global demand in support of our grower customers around the world. By the fourth quarter of 2021, we expect to surge potash production to an annualized run-rate of approximately 17 million tonnes, due to our flexible mine network and the responsiveness of our dedicated employees.
• Nutrien Ag Solutions ("Retail") delivered record adjusted EBITDA in the second quarter and first half of 2021. First-half adjusted EBITDA increased 24 percent compared to the same period in 2020 as a result of double-digit growth in revenue and gross margin, higher gross margin percentage and adjusted EBITDA margins surpassing 11 percent. The increase was primarily due to organic growth supported by strong demand for grains and oilseeds, continued growth in our proprietary product sales, optimization and efficiency initiatives, as well as, the ongoing commitment of our approximately 3,600 crop advisors to serve our grower customers.
• Sales through our digitally-enabled retail platform were approximately $1.6 billion in the first half of 2021, nearly double the sales compared to the same period in 2020 and exceeding the full year 2020 results of $1.2 billion in just six months. In the first half of 2021, we processed nearly half-a-million individual grower payments through the digital platform.
• Potash adjusted EBITDA was 48 percent higher in the second quarter and 41 percent higher in the first half of 2021 compared to the same periods in 2020 due to higher net realized selling prices and sales volumes. We achieved record production and sales volumes of nearly 7 million tonnes in the first six months of 2021.
• Nitrogen adjusted EBITDA was 45 percent higher in the second quarter and 38 percent higher in the first half of 2021 compared to the same periods in 2020 due to higher net realized selling prices. Phosphate adjusted EBITDA increased 45 percent in the second quarter and 70 percent in the first half of 2021 compared to the same periods in 2020 due to higher net realized selling prices.
• Subsequent to the second quarter of 2021, Nutrien announced an agreement to purchase Terra Nova, a retail businesses in Brazil with EBITDA margins and acquisition multiples in line with similar transaction metrics for ag retail businesses acquired by Nutrien in the US. We also entered a collaboration agreement with EXMAR NV to jointly develop and build a low-carbon, ammonia-fueled vessel to further reduce maritime transportation emissions.

___________________
^{1 This financial measure including related guidance, if applicable, is a non-IFRS financial measure. See the "Non-IFRS Financial Measures" section for further information.}

Management's Discussion and Analysis

The following management's discussion and analysis ("MD&A") is the responsibility of management and is dated as of August 9, 2021. The Board of Directors ("Board") of Nutrien carries out its responsibility for review of this disclosure principally through its audit committee, comprised exclusively of independent directors. The audit committee reviews and, prior to its publication approves this disclosure pursuant to the authority delegated to it by the Board. The term "Nutrien" refers to Nutrien Ltd. and the terms "we", "us", "our", "Nutrien" and "the Company" refer to Nutrien and, as applicable, Nutrien and its direct and indirect subsidiaries on a consolidated basis. Additional information relating to Nutrien (which, except as otherwise noted, is not incorporated by reference herein), including our 2020 Annual Report dated February 18, 2021, which includes our annual audited consolidated financial statements and MD&A, and our Annual Information Form, each for the year ended December 31, 2020, can be found on SEDAR at www.sedar.com and on EDGAR at www.sec.gov. No update is provided to the disclosure in our annual MD&A except for material information since the date of our annual MD&A. The Company is a foreign private issuer under the rules and regulations of the US Securities and Exchange Commission ("SEC").

This MD&A is based on the Company's unaudited interim condensed consolidated financial statements as at and for the three and six months ended June 30, 2021 ("interim financial statements") based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting" unless otherwise noted. This MD&A contains certain non-IFRS financial measures and forward-looking statements which are described in the "Non-IFRS Financial Measures" and the "Forward-Looking Statements" sections, respectively.

Market Outlook

Agriculture and Retail

• Crop prices continue to be supported by strong global demand and less than expected supply, resulting in historically low global inventory and strong grower margins. We expect these market fundamentals to continue beyond this season and be supportive of crop prices and grower margins into 2022.
• Growing conditions across North America vary with favorable crop conditions in the US South and East regions, and drought conditions in the Western US, US Northern Plains and Canadian Prairies. We expect this variability could impact regional crop protection and plant health product demand in the second half of 2021 as growers experiencing favorable conditions look to boost and protect yields, particularly given additional pest pressure in parts of the US this summer, while growers impacted by drought may reduce some applications. However, with the strong outlook for crop prices and assuming a normal window for fall application, we expect US fertilizer demand and post-harvest crop protection applications to be strong.
• Brazil's safrinha corn crop production estimates are significantly below initial market expectations due to both drought and frost. However, Brazilian crop prices remain at near-record highs and growers are expected to increase soybean and safrinha corn area when the next growing seasons begin. In Australia, precipitation has supported favorable soil moisture levels, leading to the largest seeded area for winter crops in the country's history.

Crop Nutrient Markets

• Global potash shipments are projected to reach a record 69 to 71 million tonnes in 2021 while inventory in key regions are expected to be historically low going into 2022. This is supported by strong potash consumption backed by favorable agricultural fundamentals, with further upside limited by global supply issues and most producers operating at peak rates.
• We believe Latin America could reach new records for both potash consumption and imports in 2021, as applications for the last crop were strong and growers are proactively securing volumes for the upcoming season. In North America, increased crop area and normal application rates have supported historically high demand which we expect will continue in the fall.
• Global nitrogen demand growth is expected to be approximately 3 percent in 2021 driven by strong agricultural fundamentals and a rebound in industrial demand. In addition, global supply is tight because of production outages and project delays, which together with higher global energy costs, have supported nitrogen prices.
• Strong global urea prices and robust global import demand led Chinese urea exports to increase by over 40 percent during the first half of 2021 compared to depressed 2020 levels. However, as a result of high Chinese domestic prices and very strong demand, the Chinese government urged producers to prioritize the domestic market, which may limit China's exports through the second half of 2021. Meanwhile, strong Indian urea demand, lower domestic production and tight inventories have resulted in regular tenders.
• Global phosphate demand remains robust in most key markets, which in combination with higher raw material costs and limited growth in export supply has continued to support phosphate prices. While inventories in India are tight, poor import economics create uncertainty for import demand in the second half of 2021.

Financial Outlook and Guidance

Based on market factors detailed above, we are raising full-year 2021 adjusted EBITDA guidance to $6.0 to $6.4 billion from $4.4 to $4.9 billion and full-year 2021 adjusted net earnings guidance to $4.60 to $5.10 per share from $2.55 to $3.25 per share.

All guidance numbers, including those noted above are outlined in the tables below. Refer to page 57 of Nutrien's 2020 Annual Report for related assumptions and sensitivities.

2021 Guidance Ranges 1		Low				High
Adjusted net earnings per share 2	$	4.60			$	5.10
Adjusted EBITDA (billions) 2	$	6.0			$	6.4
Retail Adjusted EBITDA (billions)	$	1.6			$	1.7
Potash Adjusted EBITDA (billions)	$	2.4			$	2.6
Nitrogen Adjusted EBITDA (billions)	$	1.85			$	2.05
Phosphate Adjusted EBITDA (millions)	$	400			$	500
Potash sales tonnes (millions) 3		13.5				13.9
Nitrogen sales tonnes (millions) 3		10.8				11.2
Depreciation and amortization (billions)	$	1.9			$	2.0
Effective tax rate on adjusted earnings		24	%			26	%
Sustaining capital expenditures (billions) 2	$	1.15			$	1.25
1 See the "Forward-Looking Statements" section.
2 See the "Non-IFRS Financial Measures" section.
3 Manufactured products only. Nitrogen excludes ESN® and Rainbow products.

Consolidated Results

	Three Months Ended June 30						Six Months Ended June 30
(millions of US dollars)	2021		2020		% Change		2021		2020		% Change
Sales 1	9,763		8,431		16		14,421		12,629		14
Freight, transportation and distribution	222		237		(6)		433		449		(4)
Cost of goods sold	6,659		6,024		11		9,950		9,125		9
Gross margin 1	2,882		2,170		33		4,038		3,055		32
Expenses 1	1,263		1,031		23		2,141		1,834		17
Net earnings	1,113		765		45		1,246		730		71
Adjusted EBITDA 2	2,215		1,721		29		3,021		2,229		36
Cash provided by operating activities	1,966		1,756		12		1,814		1,230		47
Free cash flow ("FCF") 2	1,413		1,173		20		1,889		1,354		40
FCF including changes in non-cash operating working capital 2	1,662		1,611		3		1,346		922		46
1 Certain immaterial figures have been reclassified for the three and six months ended June 30, 2020.
2 See the "Non-IFRS Financial Measures" section.

Net earnings and adjusted EBITDA increased significantly in the second quarter and first half of 2021 compared to the same periods in 2020 due to higher net realized selling prices, higher potash sales volumes and earnings growth in Nutrien Ag Solutions ("Retail"). Cash flow from operating activities increased in the second quarter and first half of 2021 compared to the same periods last year, which helped generate $1.9 billion in free cash flow in the first half of 2021, an increase of more than $0.5 billion compared to the amount generated in the same period in 2020. The COVID-19 pandemic had a limited impact on our results during the second quarter and first half of 2021.

Segment Results

Our discussion of segment results set out on the following pages is a comparison of the results for the three and six months ended June 30, 2021 to the results for the three and six months ended June 30, 2020, unless otherwise noted.

Nutrien Ag Solutions ("Retail")

	Three Months Ended June 30
(millions of US dollars, except	Dollars						Gross Margin						Gross Margin (%)
as otherwise noted)	2021		2020		% Change		2021		2020		% Change		2021		2020
Sales
Crop nutrients	3,045		2,527		20		703		559		26		23		22
Crop protection products	2,666		2,436		9		587		547		7		22		22
Seed	1,216		1,141		7		237		219		8		19		19
Merchandise	268		253		6		45		45		-		17		18
Nutrien Financial 1	59		40		48		59		40		48		100		100
Services and other 1	335		400		(16)		279		250		12		83		63
Nutrien Financial elimination 2	(52)		(33)		58		(52)		(33)		58		100		100
	7,537		6,764		11		1,858		1,627		14		25		24
Cost of goods sold	5,679		5,137		11
Gross margin	1,858		1,627		14
Expenses 1,3	938		826		14
Earnings before finance costs and taxes ("EBIT")	920		801		15
Depreciation and amortization	169		163		4
EBITDA	1,089		964		13
Adjustments 4	8		-		n/m
Adjusted EBITDA	1,097		964		14
1 Certain immaterial figures have been reclassified for the three months ended June 30, 2020.
2 Represents elimination for the interest and service fees charged by Nutrien Financial to Retail branches.
3 Includes selling expenses of $863 million (2020 - $764 million).
4 See Note 2 to the interim financial statements.

	Six Months Ended June 30
(millions of US dollars, except	Dollars						Gross Margin						Gross Margin (%)
as otherwise noted)	2021		2020		% Change		2021		2020		% Change		2021		2020
Sales
Crop nutrients	4,061		3,312		23		923		715		29		23		22
Crop protection products	3,751		3,446		9		763		704		8		20		20
Seed	1,679		1,535		9		306		278		10		18		18
Merchandise	498		469		6		83		79		5		17		17
Nutrien Financial 1	84		56		50		84		56		50		100		100
Services and other 1	508		655		(22)		423		384		10		83		59
Nutrien Financial elimination	(72)		(48)		50		(72)		(48)		50		100		100
	10,509		9,425		12		2,510		2,168		16		24		23
Cost of goods sold	7,999		7,257		10
Gross margin	2,510		2,168		16
Expenses 1,2	1,659		1,515		10
EBIT	851		653		30
Depreciation and amortization	346		318		9
EBITDA	1,197		971		23
Adjustments 3	9		-		n/m
Adjusted EBITDA	1,206		971		24
1 Certain immaterial figures have been reclassified for the six months ended June 30, 2020.
2 Includes selling expenses of $1,530 million (2020 - $1,399 million).
3 See Note 2 to the interim financial statements.

• Adjusted EBITDA increased in the second quarter and first half of 2021 due to higher sales, gross margin and gross margin percentages. This was supported by expanded planted acreage and strong agricultural market fundamentals in all regions in which we operate, as well as, supply chain improvements and strategic procurement. Our Retail cash operating coverage ratio¹ for the first half of 2021 declined to 60 percent.
• Crop nutrients sales increased significantly in the second quarter and first half of 2021 supported by higher prices and record North American and International first half sales volumes. Gross margin benefited from stronger margin per tonne due in part to strategic procurement in a rising price environment.
• Crop protection products sales increased in the second quarter and first half of 2021 due to market growth and favorable application conditions throughout most of the US. Gross margin percentages were stable as strategic procurement and strong proprietary product results more than offset higher costs for certain products caused by global supply chain issues.
• Seed sales increased in the second quarter and first half of 2021, supported by higher seeded acreage in key regions where we operate and strong agriculture fundamentals. Gross margin percentage was stable in the second quarter and first half of 2021.
• Merchandise sales increased in the second quarter and first half of 2021 primarily driven by growth in the Australian market due to higher animal health and management sales related to strong livestock prices. Gross margin was similar in both periods despite the shift in product mix.
• Nutrien Financial sales increased in the second quarter and first half of 2021 due to higher utilization and adoption of our programs.
• Services and other sales decreased due to the divestiture of an Australian livestock export business in the fourth quarter of 2020, which more than offset higher US custom application sales. Despite the change in revenue mix, the impact to gross margin percentage was favorable for both the second quarter and first half of 2021.

___________________
^{1 This financial measure is a non-IFRS financial measure. See the "Non-IFRS Financial Measures" section for further information.}

Potash

	Three Months Ended June 30
(millions of US dollars, except	Dollars						Tonnes (thousands)						Average per Tonne
as otherwise noted)	2021		2020	% Change			2021		2020	% Change			2021		2020	% Change
Manufactured product
Net sales
North America	326		232		41		1,172		1,201		(2)		278		194		43
Offshore	491		356		38		2,449		2,414		1		200		147		36
	817		588		39		3,621		3,615		-		226		163		39
Cost of goods sold	317		310		2								88		86		2
Gross margin - total	500		278		80								138		77		79
Expenses 1	123		52		137		Depreciation and amortization						32		30		7
EBIT	377		226		67		Gross margin excluding depreciation
Depreciation and amortization	116		109		6		and amortization - manufactured 2						170		107		59
EBITDA	493		335		47		Potash cash cost of product
Adjustments 3	2		-		n/m		manufactured 2						59		52		13
Adjusted EBITDA	495		335		48
1 Includes provincial mining taxes of $107 million (2020 - $46 million).
2 See the "Non-IFRS Financial Measures" section.
3 See Note 2 to the interim financial statements.

	Six Months Ended June 30
(millions of US dollars, except	Dollars						Tonnes (thousands)						Average per Tonne
as otherwise noted)	2021		2020	% Change			2021		2020	% Change			2021		2020	% Change
Manufactured product
Net sales
North America	658		457		44		2,642		2,348		13		249		195		28
Offshore	770		648		19		4,136		4,144		-		186		156		19
	1,428		1,105		29		6,778		6,492		4		211		170		24
Cost of goods sold	608		575		6								90		88		2
Gross margin - total	820		530		55								121		82		48
Expenses 1	187		115		63		Depreciation and amortization						35		32		9
EBIT	633		415		53		Gross margin excluding depreciation
Depreciation and amortization	240		205		17		and amortization - manufactured						156		114		37
EBITDA	873		620		41		Potash cash cost of product
Adjustments 2	2		-		n/m		manufactured						58		56		4
Adjusted EBITDA	875		620		41
1 Includes provincial mining taxes of $165 million (2020 - $103 million).
2 See Note 2 to the interim financial statements.

• Adjusted EBITDA increased in the second quarter and first half of 2021 due to higher net realized selling prices and record sales volumes.
• Sales volumes were the highest of any second quarter or first half on record. Demand was strong in both North America and Offshore markets, supported by high crop prices and good affordability, allowing us to leverage our structurally advantaged, flexible, low-cost network of six mines and integrated transportation and logistics system.
• Net realized selling price increased in the second quarter and first half of 2021 due to strong global demand and very tight supply.
• Cost of goods sold per tonne in the second quarter and first half of 2021 was slightly higher compared to the same periods in 2020, primarily due to the stronger Canadian dollar and mine production mix. These factors also led to a higher potash cash cost of product manufactured per tonne in the second quarter and first half of 2021.

Canpotex Sales by Market

(percentage of sales volumes, except as	Three Months Ended June 30				Six Months Ended June 30
otherwise noted)	2021	2020	Change		2021	2020	Change
Other Asian markets 1	41	26	15		39	28	11
Latin America	35	36	(1)		33	31	2
China	11	19	(8)		12	22	(10)
Other markets	10	7	3		11	7	4
India	3	12	(9)		5	12	(7)
	100	100			100	100
1 All Asian markets except China and India.

Nitrogen

	Three Months Ended June 30
(millions of US dollars, except	Dollars						Tonnes (thousands)						Average per Tonne
as otherwise noted)	2021		2020	% Change			2021		2020	% Change			2021		2020	% Change
Manufactured product
Net sales
Ammonia	346		229		51		836		935		(11)		416		244		70
Urea	346		273		27		819		1,000		(18)		421		273		54
Solutions, nitrates and sulfates	290		194		49		1,311		1,255		4		221		154		44
	982		696		41		2,966		3,190		(7)		331		218		52
Cost of goods sold	597		508		18								201		159		26
Gross margin - manufactured	385		188		105								130		59		120
Gross margin - other 1	31		20		55		Depreciation and amortization						52		54		(4)
Gross margin - total	416		208		100		Gross margin excluding depreciation
Expenses (income)	17		(3)		n/m		and amortization - manufactured						182		113		61
EBIT	399		211		89		Ammonia controllable cash cost of
Depreciation and amortization	155		172		(10)		product manufactured 2						51		40		28
EBITDA	554		383		45
Adjustments 3	1		-		n/m
Adjusted EBITDA	555		383		45
1 Includes other nitrogen (including ESN® and Rainbow) and purchased products and is comprised of net sales of $197 million (2020 - $157 million) less cost of goods sold of $166 million (2020 - $137 million).
2 See the "Non-IFRS Financial Measures" section.
3 See Note 2 to the interim financial statements.

	Six Months Ended June 30
(millions of US dollars, except	Dollars						Tonnes (thousands)						Average per Tonne
as otherwise noted)	2021		2020	% Change			2021		2020	% Change			2021		2020	% Change
Manufactured product
Net sales
Ammonia	506		359		41		1,408		1,502		(6)		360		239		51
Urea	595		510		17		1,576		1,856		(15)		377		275		37
Solutions, nitrates and sulfates	454		357		27		2,385		2,360		1		190		151		26
	1,555		1,226		27		5,369		5,718		(6)		290		214		36
Cost of goods sold	1,037		952		9								194		166		17
Gross margin - manufactured	518		274		89								96		48		100
Gross margin - other 1	48		31		55		Depreciation and amortization						53		56		(5)
Gross margin - total	566		305		86		Gross margin excluding depreciation
Expenses	-		8		(100)		and amortization - manufactured						149		104		43
EBIT	566		297		91		Ammonia controllable cash cost of
Depreciation and amortization	284		322		(12)		product manufactured						51		43		19
EBITDA	850		619		37
Adjustments 2	5		-		n/m
Adjusted EBITDA	855		619		38
1 Includes other nitrogen (including ESN® and Rainbow) and purchased products and is comprised of net sales of $384 million (2020 - $305 million) less cost of goods sold of $336 million (2020 - $274 million).
2 See Note 2 to the interim financial statements.

• Adjusted EBITDA increased in the second quarter and first half of 2021 due to higher net realized selling prices which more than offset higher natural gas costs, lower equity earnings and lower sales volumes.
• Sales volumes were lower in the second quarter and first half of 2021 due to higher turnaround activities, temporary production outages and lower inventories at the beginning of 2021. Our ammonia operating rate was 87 percent and 92 percent respectively in the second quarter and first half of 2021.
• Net realized selling price of nitrogen in the second quarter and first half of 2021 was higher due to higher benchmark prices resulting from the strength in global agriculture markets and a recovery in industrial nitrogen demand.
• Cost of goods sold per tonne increased during the second quarter and first half of 2021 due to higher natural gas costs, a stronger Canadian dollar and lower nitrogen production. The stronger Canadian dollar combined with lower production volumes led to a higher ammonia controllable cash cost of product manufactured per tonne in the second quarter and first half of 2021.

Natural Gas Prices in Cost of Production

	Three Months Ended June 30						Six Months Ended June 30
(US dollars per MMBtu, except as otherwise noted)	2021		2020		% Change		2021		2020		% Change
Overall gas cost excluding realized derivative impact	3.86		2.09		85		3.51		2.16		63
Realized derivative impact	0.03		0.06		(50)		0.03		0.06		(50)
Overall gas cost	3.89		2.15		81		3.54		2.22		59
Average NYMEX	2.83		1.72		65		2.76		1.83		51
Average AECO	2.32		1.37		69		2.31		1.50		54

• Natural gas prices in our cost of production increased in the second quarter and first half of 2021 as a result of higher North American gas index prices and increased gas costs in Trinidad, which are linked to ammonia benchmark prices.

Phosphate

	Three Months Ended June 30
(millions of US dollars, except	Dollars						Tonnes (thousands)						Average per Tonne
as otherwise noted)	2021		2020	% Change			2021		2020	% Change			2021		2020	% Change
Manufactured product
Net sales
Fertilizer	232		146		59		394		472		(17)		588		309		90
Industrial and feed	119		104		14		192		194		(1)		621		538		15
	351		250		40		586		666		(12)		598		375		59
Cost of goods sold	271		224		21								463		335		38
Gross margin - manufactured	80		26		208								135		40		238
Gross margin - other 1	4		2		100		Depreciation and amortization						60		84		(29)
Gross margin - total	84		28		200		Gross margin excluding depreciation
Expenses	7		7		-		and amortization - manufactured						195		124		57
EBIT	77		21		267
Depreciation and amortization	35		56		(38)
EBITDA / Adjusted EBITDA	112		77		45
1 Includes other phosphate and purchased products and is comprised of net sales of $52 million (2020 - $27 million) less cost of goods sold of $48 million (2020 - $25 million).

	Six Months Ended June 30
(millions of US dollars, except	Dollars						Tonnes (thousands)						Average per Tonne
as otherwise noted)	2021		2020	% Change			2021		2020	% Change			2021		2020	% Change
Manufactured product
Net sales
Fertilizer	462		319		45		903		1,040		(13)		511		307		66
Industrial and feed	233		210		11		385		385		-		605		546		11
	695		529		31		1,288		1,425		(10)		539		372		45
Cost of goods sold	553		511		8								429		359		19
Gross margin - manufactured	142		18		689								110		13		746
Gross margin - other 1	8		3		167		Depreciation and amortization						57		84		(32)
Gross margin - total	150		21		614		Gross margin excluding depreciation
Expenses	14		17		(18)		and amortization - manufactured						167		97		72
EBIT	136		4		n/m
Depreciation and amortization	73		119		(39)
EBITDA / Adjusted EBITDA	209		123		70
1 Includes other phosphate and purchased products and is comprised of net sales of $93 million (2020 - $61 million) less cost of goods sold of $85 million (2020 - $58 million).

• Adjusted EBITDA increased in the second quarter and first half of 2021 due to higher net realized selling prices which more than offset higher raw material costs and lower sales volumes.
• Sales volumes were lower in the second quarter and first half of 2021 due to the timing of turnaround activity this year and higher inventory tonnes in 2020 which supported higher sales in the second quarter and first half of 2020.
• Net realized selling price of phosphate fertilizer increased in the second quarter and first half of 2021 as a result of the increase in benchmark fertilizer prices resulting from the strength in global agriculture markets and higher global raw material costs. Industrial and feed prices also increased, but to a lesser extent than fertilizer, due to a lag in price realizations relative to spot prices.
• Cost of goods sold per tonne increased due to significantly higher raw material input costs and a $46 million favorable change in estimate related to an asset retirement obligation recorded in the second quarter of 2020. This was partially offset by lower depreciation and amortization following the non-cash impairment of assets in the third quarter of 2020.

Corporate and Others

(millions of US dollars, except as otherwise	Three Months Ended June 30						Six Months Ended June 30
noted)	2021		2020		% Change		2021		2020		% Change
Sales 1	-		20		(100)		-		47		(100)
Cost of goods sold	-		18		(100)		-		43		(100)
Gross margin	-		2		(100)		-		4		(100)
Selling expenses	(9)		(8)		13		(15)		(13)		15
General and administrative expenses	66		65		2		124		125		(1)
Share-based compensation expense (recovery)	38		12		217		61		(20)		n/m
Other expenses	83		80		4		111		87		28
EBIT	(178)		(147)		21		(281)		(175)		61
Depreciation and amortization	10		17		(41)		22		26		(15)
EBITDA	(168)		(130)		29		(259)		(149)		74
Adjustments 2	100		65		54		143		18		694
Adjusted EBITDA	(68)		(65)		5		(116)		(131)		(11)
1 Primarily relates to our non-core Canadian business that was sold in 2020.
2 See Note 2 to the interim financial statements.

• Share-based compensation expense (recovery) - In the second quarter of 2021, the expense was higher as a result of the increase in our share price. We also had a higher number of share-based awards that vested in 2021.
  
  We had an expense in the first half of 2021 due to an increase in our share price, while a recovery was recorded in the first half of 2020 as our share price decreased as a result of market volatility caused by the COVID-19 pandemic.

• Other expenses were higher in the second quarter and first half of 2021 compared to the same periods in 2020 as we recognized additional cloud computing related expenses from our change in accounting policy (refer to Note 3). This was partially offset by lower foreign exchange losses as Canadian and Australian dollars improved relative to the US dollar in the second quarter of 2021.

Finance Costs, Income Tax Expense and
Other Comprehensive Income (Loss)

(millions of US dollars, except as otherwise	Three Months Ended June 30						Six Months Ended June 30
noted)	2021		2020		% Change		2021		2020		% Change
Finance costs	125		139		(10)		245		272		(10)
Income tax expense	381		235		62		406		219		85
Other comprehensive income (loss)	61		201		(70)		85		(157)		n/m

• Finance costs in the second quarter and first half of 2021 were lower due to lower interest rates and a lower short-term debt balance, more than offsetting a higher long-term debt balance resulting from the $1.5 billion in notes issued in the second quarter of 2020.
• Income tax expense in the second quarter and first half of 2021 was higher as a result of higher earnings before income taxes compared to the same periods in 2020.
• Other comprehensive income (loss) is primarily driven by changes in the currency translation of our foreign operations and our investment in Sinofert Holdings Ltd. ("Sinofert"). In 2020, the COVID-19 pandemic resulted in increased market volatility that affected share prices and foreign exchange rates. This resulted in fair value losses on our investment in Sinofert as well as a significant translation gain in the second quarter of 2020 and a significant translation loss in the first quarter of 2020. In the first half of 2021, Sinofert share price increased while the Canadian and Australian dollars relative to the US dollar were less volatile.

Liquidity and Capital Resources

Sources and Uses of Liquidity

We continued to manage our capital in accordance with our capital allocation strategy. We believe that our internally generated cash flow, supplemented by available borrowings under our existing financing sources, if necessary, will be sufficient to meet our anticipated capital expenditures and other cash requirements for the foreseeable future. Refer to the "Capital Structure and Management" section for details on our existing long-term debt and credit facilities.

Sources and Uses of Cash

(millions of US dollars, except as otherwise	Three Months Ended June 30						Six Months Ended June 30
noted)	2021		2020		% Change		2021		2020		% Change
Cash provided by operating activities	1,966		1,756		12		1,814		1,230		47
Cash used in investing activities	(431)		(408)		6		(819)		(853)		(4)
Cash (used in) provided by financing activities	(449)		(3,139)		(86)		(640)		380		n/m
Effect of exchange rate changes on cash and cash equivalents	(4)		24		n/m		(15)		(13)		15
Increase (decrease) in cash and cash equivalents	1,082		(1,767)		n/m		340		744		(54)

Cash provided by operating activities	Higher cash provided by operating activities in the second quarter and first half of 2021 compared to the same periods in 2020 was primarily due to strong global crop and fertilizer markets, which resulted in higher earnings, combined with improvements to working capital management, the most significant of which was an increase in payables and accrued charges related to a shift in timing of supplier payments.
Cash used in investing activities	Higher cash used in investing activities in the second quarter was primarily due to higher additions to our property, plant and equipment from higher turnaround activities compared to the same period in 2020. Lower cash used in investing activities for the first half of 2021 was primarily due to lower acquisitions compared to the same period in 2020.
Cash (used in) provided by financing activities	Lower cash used in financing activities for the second quarter of 2021 compared to the second quarter of 2020 was due to minimal debt repayments in 2021. In 2020, as we managed our liquidity needs during the initial period of the COVID-19 pandemic, we repaid $4.3 billion of short-term debt and issued $1.5 billion of notes. Cash used in financing activities for the first half of 2021 compared to cash provided by financing activities in the first half of 2020 was primarily due to the issuance of $1.5 billion of notes and a note repayment of $500 million in the first half of 2020. We did not issue or repay notes in the first half of 2021.

Financial Condition Review

The following balance sheet categories contained variances that were considered significant:

	As at
(millions of US dollars, except as otherwise noted)	June 30, 2021		December 31, 2020		$ Change		% Change
Assets
Cash and cash equivalents	1,794		1,454		340		23
Receivables	6,683		3,626		3,057		84
Prepaid expenses and other current assets	524		1,460		(936)		(64)
Other assets	664		914		(250)		(27)
Liabilities and Equity
Payables and accrued charges	9,367		8,058		1,309		16
Retained earnings	7,315		6,606		709		11

• Explanations for changes in Cash and cash equivalents are in the "Sources and Uses of Cash" section.
• Receivables increased due to higher sales across all of our segments. This was a result of increased crop nutrient net realized selling prices and demand for crop inputs, as well as higher Retail vendor rebates receivables. Certain income tax receivables previously classified as non-current are currently realizable within one year.
• Prepaid expenses and other current assets decreased due to Retail taking delivery of prepaid inventory (primarily seed and crop protection) during the spring planting and application seasons.
• Other assets decreased due to a reclassification of certain income tax receivables as current receivables, which will be realized within one year.
• Payables and accrued charges increased due to a shift in timing of supplier payments and higher inventory purchases to meet strong seasonal demand, which were partially offset by lower customer prepayments in North America as Retail customers took delivery of prepaid sales.
• Retained earnings increased as net earnings in the first half of 2021 exceeded dividends declared.

Capital Structure and Management

Principal Debt Instruments

As part of the normal course of business, we closely monitor our liquidity position. We use a combination of cash generated from operations and short-term and long-term debt to finance our operations. We were in compliance with our debt covenants and did not have any changes to our credit ratings in the six months ended June 30, 2021.

	As at June 30, 2021
			Outstanding and Committed
(millions of US dollars)	Rate of Interest (%)	Total Facility Limit	Short-term debt	Long-term debt
Credit facilities
Unsecured revolving term credit facility	n/a	4,500	-	-
Uncommitted revolving demand facility	n/a	500	-	-
Other credit facilities 1	0.9 - 7.5	630	115	73
Other	n/a		95	-
Total			210	73
1 Other credit facilities are unsecured and consist of South American facilities with debt of $167 million and interest rates ranging from 1.5 percent to 7.5 percent and other facilities with debt of $21 million and interest rates ranging from 0.9 percent to 4.1 percent.

We also have a commercial paper program, which is limited to the availability of backup funds under the $4,500 million unsecured revolving term credit facility and excess cash invested in highly liquid securities. There is no outstanding balance as of June 30, 2021.

We extended the maturity date of the unsecured revolving term credit facility from 2023 to 2026 in the three months ended June 30, 2021. There was no change to the total facility limit or the significant agreement terms from those we disclosed in our 2020 Annual Report.

Our long-term debt consists primarily of notes. See the "Capital Structure and Management" section of our 2020 Annual Report for information on balances, rates and maturities for our notes.

Outstanding Share Data

	As at August 6, 2021
Common shares	570,688,867
Options to purchase common shares	9,877,776

For more information on our capital structure and management, see Note 24 to our 2020 financial statements.

Quarterly Results

(millions of US dollars, except as otherwise noted)	Q2 2021	Q1 2021		Q4 2020		Q3 2020		Q2 2020		Q1 2020		Q4 2019		Q3 2019
Sales 1	9,763		4,658		4,052		4,227		8,431		4,198		3,462		4,185
Net earnings (loss) attributable to equity holders of Nutrien	1,108		127		316		(587)		765		(35)		(48)		141
Adjusted EBITDA	2,215		806		768		670		1,721		508		664		787
Net earnings (loss) per share attributable to equity holders of Nutrien
Basic	1.94		0.22		0.55		(1.03)		1.34		(0.06)		(0.08)		0.25
Diluted	1.94		0.22		0.55		(1.03)		1.34		(0.06)		(0.08)		0.24
1 Certain immaterial figures have been reclassified in the first three quarters of 2020.

Seasonality in our business results from increased demand for products during the planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop nutrient inventories are normally accumulated leading up to each application season. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

In the third quarter of 2020, earnings were impacted by an $824 million non-cash impairment of assets primarily in the Phosphate segment as a result of lower forecasted global phosphate prices. In the fourth quarter of 2020, earnings were impacted by a $250 million net gain on disposal of our investment in Misr Fertilizers Production Company S.A.E. ("MOPCO").

Critical Accounting Estimates

Our significant accounting policies are disclosed in our 2020 Annual Report. We have discussed the development, selection and application of our key accounting policies, and the critical accounting estimates and assumptions they involve, with the audit committee of the Board. Our critical accounting estimates are discussed on page 53 of our 2020 Annual Report. There were no significant changes in the six months ended June 30, 2021 to our critical accounting estimates.

Controls and Procedures

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended, and National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings. Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with IFRS. Any system of internal control over financial reporting, no matter how well designed, has inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

There has been no change in our internal control over financial reporting during the three months ended June 30, 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Forward-Looking Statements

Certain statements and other information included in this document, including within the "Financial Outlook and Guidance" section, constitute "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") under applicable securities laws (such statements are often accompanied by words such as "anticipate", "forecast", "expect", "believe", "may", "will", "should", "estimate", "intend" or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to: Nutrien's business strategies, plans, prospects and opportunities; Nutrien's full-year guidance, including expectations regarding our adjusted net earnings per share and adjusted EBITDA (consolidated and by segment); expectations regarding our growth and capital allocation intentions and strategies; capital spending expectations for 2021; expectations regarding performance of our operating segments in 2021, including our operating segment market outlooks and market conditions for 2021, and the anticipated supply and demand for our products and services, expected market and industry conditions with respect to crop nutrient application rates, planted acres, crop mix, prices and the impact of import and export volumes; Nutrien's ability to develop innovative and sustainable solutions; the negotiation of sales contracts; and acquisitions and divestitures. These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place an undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty. The additional key assumptions that have been made include, among other things, assumptions with respect to our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures, and that we will be able to implement our standards, controls, procedures and policies in respect of any acquired businesses and to realize the expected synergies; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, margins, demand, supply, product availability, supplier agreements, availability and cost of labor and interest, exchange and effective tax rates; assumptions with respect to global economic conditions and the accuracy of our market outlook expectations for 2021 and in the future; our expectations regarding the impacts, direct and indirect, of the COVID-19 pandemic on our business, customers, business partners, employees, supply chain, other stakeholders and the overall economy; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; our ability to maintain investment grade ratings and achieve our performance targets; our ability to successfully negotiate sales contracts; and our ability to successfully implement new initiatives and programs.

Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to complete announced and future acquisitions or divestitures at all or on the expected terms and within the expected timeline; climate change and weather conditions, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including tariffs, trade restrictions and climate change initiatives), government ownership requirements, changes in environmental, tax and other laws or regulations and the interpretation thereof; political risks, including civil unrest, actions by armed groups or conflict and malicious acts including terrorism; the occurrence of a major environmental or safety incident; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; the COVID-19 pandemic, including variants of the COVID-19 virus and the efficiency and distribution of vaccines, and its resulting effects on economic conditions, restrictions imposed by public health authorities or governments, fiscal and monetary responses by governments and financial institutions and disruptions to global supply chains; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the SEC in the United States.

The purpose of our expected adjusted net earnings per share, adjusted EBITDA (consolidated and by segment) and sustaining capital expenditures guidance ranges, are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.

Terms and Definitions

For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the "Terms and Definitions" section of our 2020 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, "n/m" indicates information that is not meaningful and all financial amounts are stated in millions of US dollars, unless otherwise noted.

About Nutrien

Nutrien is the world's largest provider of crop inputs and services, playing a critical role in helping growers increase food production in a sustainable manner. We produce and distribute approximately 27 million tonnes of potash, nitrogen and phosphate products world-wide. With this capability and our leading agriculture retail network, we are well positioned to supply the needs of our customers. We operate with a long-term view and are committed to working with our stakeholders as we address our economic, environmental and social priorities. The scale and diversity of our integrated portfolio provides a stable earnings base, multiple avenues for growth and the opportunity to return capital to shareholders.

Selected financial data for download can be found in our data tool at www.nutrien.com/investors/interactive-datatool

Such data is not incorporated by reference herein.

Nutrien will host a Conference Call on Tuesday, August 10, 2021 at 10:00 am Eastern Time.

• In order to expedite access to our conference call, each participant will be required to pre-register for the event:
  • Online: http://www.directeventreg.com/registration/event/3792844.
  • Via Phone: 1-888-869-1189 Conference ID 3792844.
• Once the registration is complete, a confirmation will be sent providing the dial in number and both the Direct Event Passcode and your unique Registrant ID to join this call. For security reasons, please do not share your information with anyone else.
• Live Audio Webcast: Visit http://www.nutrien.com/investors/events/2021-q2-earnings-conference-call

Appendix A - Selected Additional Financial Data

Selected Retail measures	Three Months Ended June 30				Six Months Ended June 30
	2021		2020		2021		2020
Proprietary products margin as a percentage of product line margin (%)
Crop nutrients	24		24		23		26
Crop protection products	43		42		42		42
Seed	46		47		43		44
All products	29		29		27		28
Crop nutrients sales volumes (tonnes - thousands)
North America	5,020		5,098		6,617		6,524
International	1,132		1,024		1,935		1,623
Total	6,152		6,122		8,552		8,147
Crop nutrients selling price per tonne
North America	506		427		494		425
International	445		340		408		332
Total	495		413		475		406
Crop nutrients gross margin per tonne
North America	127		101		123		100
International	57		42		54		40
Total	114		91		108		88
Financial performance measures							2021
Retail adjusted EBITDA to sales ("Retail adjusted EBITDA margin") (%) 1							10
Retail adjusted average working capital to sales (%) 1, 2							12
Retail adjusted average working capital to sales excluding Nutrien Financial (%) 1, 2							-
Retail cash operating coverage ratio (%) 1, 2							60
Retail normalized comparable store sales (%) 2							1
Retail adjusted EBITDA per US selling location (thousands of US dollars) 1, 2							1,267
Nutrien Financial net interest margin (%) 1, 2							6.2
1 Rolling four quarters ended June 30, 2021.
2 See the "Non-IFRS Financial Measures" section.

Nutrien Financial	As at June 30, 2021
(millions of US dollars)	Current	<31 days past due	31-90 days past due	>90 days past due	Gross Receivables	Allowance 1	Total
North America	2,530	152	56	48	2,786	(31)	2,755
International	230	12	14	63	319	(2)	317
Nutrien Financial receivables	2,760	164	70	111	3,105	(33)	3,072
1 Bad debt expense on the above receivables for the three months ended June 30, 2021 was $11 million (2020 - $12 million) in the Retail segment.

Selected Nitrogen measures	Three Months Ended June 30				Six Months Ended June 30
	2021		2020		2021		2020
Sales volumes (tonnes - thousands)
Fertilizer	1,825		2,173		3,130		3,584
Industrial and feed	1,141		1,017		2,239		2,134
Net sales (millions of US dollars)
Fertilizer	638		510		970		828
Industrial and feed	344		186		585		398
Net selling price per tonne
Fertilizer	350		235		310		231
Industrial and feed	302		182		261		186

Production measures	Three Months Ended June 30				Six Months Ended June 30
	2021		2020		2021		2020
Potash production (Product tonnes - thousands)	3,414		3,346		6,950		6,381
Potash shutdown weeks 1	4		22		4		34
Ammonia production - total 2	1,492		1,619		2,941		3,066
Ammonia production - adjusted 2, 3	954		1,067		2,007		2,058
Ammonia operating rate (%) 3	87		97		92		94
P2O5 production (P2O5 tonnes - thousands)	347		357		725		729
P2O5 operating rate (%)	82		84		86		86
1 Represents weeks of full production shutdown, excluding the impact of any periods of reduced operating rates and planned routine annual maintenance shutdowns and announced workforce reductions.
2 All figures are provided on a gross production basis in thousands of product tonnes.
3 Excludes Trinidad and Joffre.

Appendix B - Non-IFRS Financial Measures

We use both IFRS and certain non-IFRS financial measures to assess performance. Non-IFRS financial measures are numerical measures of a company's historical or future financial performance, financial position or cash flow that are not specified, defined or determined under IFRS, and are not presented in our interim financial statements. Non-IFRS measures either exclude amounts that are included in, or include amounts that are excluded from, the most directly comparable measure specified, defined or determined under IFRS. In evaluating these measures, investors should consider that the methodology applied in calculating such measures may differ among companies and analysts.

Management believes the non-IFRS financial measures provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-IFRS financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

The following section outlines our non-IFRS financial measures, their definitions, and why management uses each measure. It includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-IFRS financial measures are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As non-recurring or unusual items arise, we generally exclude these items in our calculation of the applicable non-IFRS financial measure.

Adjusted EBITDA (Consolidated)

Most directly comparable IFRS financial measure: Net earnings (loss).

Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, certain integration and restructuring related costs, share-based compensation, impairment of assets, certain foreign exchange gain/loss (net of related derivatives), COVID-19 related expenses, cloud computing transition adjustment, loss on disposal of business, and net gain on disposal of investment in MOPCO. COVID-19 related expenses primarily consist of increased cleaning and sanitization costs, the purchase of personal protective equipment, discretionary supplemental employee costs and costs related to construction delays from access limitations and other government restrictions. Cloud computing transition adjustment relates to cloud computing costs in prior years that no longer qualify for capitalization based on an agenda decision issued by the IFRS Interpretations Committee in April 2021. In 2021, we amended our calculation of adjusted EBITDA to adjust for the impact of restructuring and related costs and cloud computing transition adjustment. There were no similar expenses in the comparative period.

Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations.

	Three Months Ended June 30				Six Months Ended June 30
(millions of US dollars)	2021		2020		2021		2020
Net earnings	1,113		765		1,246		730
Finance costs	125		139		245		272
Income tax expense	381		235		406		219
Depreciation and amortization	485		517		965		990
EBITDA	2,104		1,656		2,862		2,211
Integration and restructuring related costs	29		18		39		28
Share-based compensation expense (recovery)	38		12		61		(20)
Impairment of assets	1		-		5		-
COVID-19 related expenses	9		17		18		19
Foreign exchange (gain) loss, net of related derivatives	(2)		18		-		(9)
Cloud computing transition adjustment	36		-		36		-
Adjusted EBITDA	2,215		1,721		3,021		2,229

Adjusted EBITDA (Consolidated), Adjusted Net Earnings Per Share and Sustaining Capital Expenditures Guidance

Adjusted EBITDA, adjusted net earnings per share and sustaining capital expenditures guidance are forward-looking non-IFRS financial measures. We do not provide a reconciliation of such forward-looking measures to the most directly comparable financial measures calculated and presented in accordance with IFRS due to unknown variables and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine, without unreasonable efforts. Guidance for adjusted EBITDA and adjusted net earnings per share excludes the impacts of integration and restructuring related costs, share-based compensation, certain foreign exchange gain/loss (net of related derivatives), COVID-19 related expenses, and cloud computing transition adjustment. Guidance for sustaining capital expenditures includes expected expenditures required to sustain operations at existing levels and includes major repairs and maintenance and plant turnarounds.

Adjusted Net Earnings and Adjusted Net Earnings Per Share

Most directly comparable IFRS financial measure: Net earnings (loss) and net earnings (loss) per share.

Definition: Net earnings (loss) before certain integration and restructuring related costs, share-based compensation, certain foreign exchange gain/loss (net of related derivatives), COVID-19 related expenses (including those recorded under finance costs for managing our liquidity position in response to the COVID-19 pandemic in 2020), cloud computing transition adjustment, loss on disposal of business, net gain on disposal of investment in MOPCO and impairment of assets, net of tax. We generally apply the annual forecasted effective tax rate to our adjustments during the year and, at year-end, we apply the actual effective tax rate. If the effective tax rate is significantly different from our forecasted effective tax rate due to adjustments or discrete tax impacts, we apply a tax rate that excludes those items. For material adjustments, we apply a tax rate specific to the adjustment. In 2021, we amended our calculation of adjusted net earnings to adjust for the impact of restructuring and related costs and cloud computing transition adjustment. There were no similar expenses in the comparative period.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations excluding the effects of non-operating items.

	Three Months Ended June 30, 2021						Six Months Ended June 30, 2021
					Per						Per
(millions of US dollars, except as otherwise	Increases				Diluted		Increases				Diluted
noted)	(Decreases)		Post-Tax		Share		(Decreases)		Post-Tax		Share
Net earnings attributable to equity holders of Nutrien			1,108		1.94				1,235		2.16
Adjustments:
Integration and restructuring related costs	29		22		0.03		39		30		0.05
Share-based compensation expense	38		29		0.05		61		46		0.08
Impairment of assets	1		1		-		5		4		0.01
COVID-19 related expenses	9		7		0.01		18		14		0.02
Foreign exchange gain, net of related derivatives	(2)		(2)		-		-		-		-
Cloud computing transition adjustment	36		27		0.05		36		27		0.05
Adjusted net earnings			1,192		2.08				1,356		2.37

Free Cash Flow and Free Cash Flow Including Changes in Non-Cash Operating Working Capital

Most directly comparable IFRS financial measure: Cash from operations before working capital changes.

Definition: Cash from operations before working capital changes less sustaining capital expenditures. We also calculate a similar measure that includes changes in non-cash operating working capital.

Why we use the measure and why it is useful to investors: For evaluation of liquidity and financial strength. These are also useful as indicators of our ability to service debt, meet other payment obligations and make strategic investments. These do not represent residual cash flow available for discretionary expenditures.

	Three Months Ended June 30				Six Months Ended June 30
(millions of US dollars)	2021		2020		2021		2020
Cash from operations before working capital changes	1,717		1,318		2,357		1,662
Sustaining capital expenditures	(304)		(145)		(468)		(308)
Free cash flow	1,413		1,173		1,889		1,354
Changes in non-cash operating working capital	249		438		(543)		(432)
Free cash flow including changes in non-cash operating working capital	1,662		1,611		1,346		922

Potash Cash Cost of Product Manufactured ("COPM")

Most directly comparable IFRS financial measure: Cost of goods sold ("COGS") for the Potash segment.

Definition: Potash COGS for the period excluding depreciation and amortization expense and inventory and other adjustments divided by the production tonnes for the period.

Why we use the measure and why it is useful to investors: To assess operational performance. Potash cash COPM excludes the effects of production from other periods and long-term investment decisions, supporting a focus on the performance of our day-to-day operations.

	Three Months Ended June 30				Six Months Ended June 30
(millions of US dollars, except as otherwise noted)	2021		2020		2021		2020
Total COGS - Potash	317		310		608		575
Change in inventory	(11)		(40)		16		(32)
Other adjustments	(2)		(3)		(6)		(5)
COPM	304		267		618		538
Depreciation and amortization included in COPM	(103)		(92)		(214)		(181)
Cash COPM	201		175		404		357
Production tonnes (tonnes - thousands)	3,414		3,346		6,950		6,381
Potash cash COPM per tonne	59		52		58		56

Ammonia Controllable Cash COPM

Most directly comparable IFRS financial measure: COGS for the Nitrogen segment.

Definition: The total of COGS for the Nitrogen segment excluding depreciation and amortization expense included in COGS, cash COGS for products other than ammonia, other adjustments, and natural gas and steam costs, divided by net ammonia production tonnes.

Why we use the measure and why it is useful to investors: To assess operational performance. Ammonia controllable cash COPM excludes the effects of production from other periods, the costs of natural gas and steam, and long-term investment decisions, supporting a focus on the performance of our day-to-day operations.

	Three Months Ended June 30				Six Months Ended June 30
(millions of US dollars, except as otherwise noted)	2021		2020		2021		2020
Total COGS - Nitrogen	763		645		1,373		1,226
Depreciation and amortization in COGS	(134)		(152)		(242)		(282)
Cash COGS for products other than ammonia	(448)		(369)		(841)		(730)
Ammonia
Total cash COGS before other adjustments	181		124		290		214
Other adjustments 1	(27)		(46)		(30)		(35)
Total cash COPM	154		78		260		179
Natural gas and steam costs	(118)		(53)		(192)		(119)
Controllable cash COPM	36		25		68		60
Production tonnes (net tonnes 2 - thousands)	703		644		1,305		1,388
Ammonia controllable cash COPM per tonne	51		40		51		43
1 Includes changes in inventory balances and other adjustments.
2 Ammonia tonnes available for sale, as not upgraded to other Nitrogen products.

Gross Margin Excluding Depreciation and Amortization Per Tonne - Manufactured

Most directly comparable IFRS financial measure: Gross margin.

Definition: Gross margin from manufactured products per tonne less depreciation and amortization per tonne. Reconciliations are provided in the "Segment Results" section.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

Retail Adjusted Average Working Capital to Sales and Retail Adjusted Average Working Capital to Sales Excluding Nutrien Financial

Most directly comparable IFRS financial measure: (Current assets minus current liabilities for Retail) divided by Retail sales.

Definition: Retail adjusted average working capital divided by Retail adjusted sales for the last four rolling quarters. We exclude in our calculations the working capital and sales of certain acquisitions (such as Ruralco) during the first year following the acquisition. We amended our calculation to adjust for the sales of certain recently acquired businesses. We also look at this metric excluding the sales and working capital of Nutrien Financial.

Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively. The metric excluding Nutrien Financial shows the impact that the working capital of Nutrien Financial has on the ratio.

	Rolling four quarters ended June 30, 2021
(millions of US dollars, except as otherwise noted)	Q3 2020		Q4 2020		Q1 2021		Q2 2021		Average/Total
Working capital	3,216		1,157		1,630		1,348
Working capital from certain recent acquisitions	-		-		-		-
Adjusted working capital	3,216		1,157		1,630		1,348		1,838
Nutrien Financial working capital	(1,711)		(1,392)		(1,221)		(3,072)
Adjusted working capital excluding Nutrien Financial	1,505		(235)		409		(1,724)		(11)
Sales 1	2,742		2,618		2,972		7,537
Sales from certain recent acquisitions	-		-		-		-
Adjusted sales	2,742		2,618		2,972		7,537		15,869
Nutrien Financial revenue 1	(36)		(37)		(25)		(59)
Adjusted sales excluding Nutrien Financial	2,706		2,581		2,947		7,478		15,712
1 Certain immaterial figures have been reclassified for the third quarter of 2020.
Adjusted average working capital to sales (%)									12
Adjusted average working capital to sales excluding Nutrien Financial (%)									-

Nutrien Financial Net Interest Margin

Most directly comparable IFRS financial measure: Nutrien Financial gross margin divided by average Nutrien Financial receivables.

Definition: Nutrien Financial revenue less deemed interest expense divided by average Nutrien Financial receivables outstanding for the last four rolling quarters.

Why we use the measure and why it is useful to investors: Used by credit rating agencies and other users to evaluate financial performance of Nutrien Financial.

	Rolling four quarters ended June 30, 2021
(millions of US dollars, except as otherwise noted)	Q3 2020		Q4 2020		Q1 2021		Q2 2021		Total/Average
Nutrien Financial revenue	36		37		25		59
Deemed interest expense 1	(15)		(14)		(6)		(8)
Net interest	21		23		19		51		114
Average Nutrien Financial receivables	1,711		1,392		1,221		3,072		1,849
Nutrien Financial net interest margin (%)									6.2
1 Average borrowing rate applied to the notional debt required to fund the portfolio of receivables from customers monitored and serviced by Nutrien Financial.

Retail Cash Operating Coverage Ratio

Most directly comparable IFRS financial measure: Retail operating expenses as a percentage of Retail gross margin.

Definition: Retail operating expenses, excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate free cash flow.

	Rolling four quarters ended June 30, 2021
(millions of US dollars, except as otherwise noted)	Q3 2020		Q4 2020		Q1 2021		Q2 2021		Total
Operating expenses 1, 2	691		768		721		938		3,118
Depreciation and amortization in operating expenses	(167)		(177)		(175)		(166)		(685)
Operating expenses excluding depreciation and amortization	524		591		546		772		2,433
Gross margin 2	683		885		652		1,858		4,078
Depreciation and amortization in cost of goods sold	3		3		2		3		11
Gross margin excluding depreciation and amortization	686		888		654		1,861		4,089
Cash operating coverage ratio (%)									60
1 Includes Retail expenses below gross margin including selling expenses, general and administrative expenses and other (income) expenses.
2 Certain immaterial figures have been reclassified for the third quarter of 2020.

Retail Adjusted EBITDA per US Selling Location

Most directly comparable IFRS financial measure: Retail US adjusted EBITDA.

Definition: Total Retail US adjusted EBITDA for the last four rolling quarters, adjusted for acquisitions in those quarters, divided by the number of US locations that have generated sales in the last four rolling quarters, adjusted for acquired locations.

Why we use the measure and why it is useful to investors: To assess our US Retail operating performance. This measure includes locations we have owned for more than 12 months.

	Rolling four quarters ended June 30, 2021
(millions of US dollars, except as otherwise noted)	Q3 2020		Q4 2020		Q1 2021		Q2 2021		Total
Adjusted US EBITDA	86		177		29		847		1,139
Adjustments for acquisitions									(5)
Adjusted US EBITDA adjusted for acquisitions									1,134
Number of US selling locations adjusted for acquisitions									895
Adjusted EBITDA per US selling location (thousands of US dollars)									1,267

Retail Normalized Comparable Store Sales

Most directly comparable IFRS financial measure: Retail sales from comparable base as a component of total Retail sales.

Definition: Prior year comparable store sales adjusted for published potash, nitrogen and phosphate benchmark prices and foreign exchange rates used in the current year. We retain sales of closed locations in the comparable base if the closed location is in close proximity to an existing location, unless we plan to exit the market area or are unable to economically or logistically serve it. We do not adjust for temporary closures, expansions or renovations of stores.

Why we use the measure and why it is useful to investors: To evaluate sales growth by adjusting for fluctuations in commodity prices and foreign exchange rates. Includes locations we have owned for more than 12 months.

	Six Months Ended June 30
(millions of US dollars, except as otherwise noted)	2021		2020
Sales from comparable base
Current period	10,405		8,602
Prior period 1	9,425		8,551
Comparable store sales (%)	10		1
Prior period normalized for benchmark prices and foreign exchange rates 1	10,351		8,104
Normalized comparable store sales (%)	1		6
1 Certain immaterial figures have been reclassified in 2020.

Condensed Consolidated Financial Statements

Unaudited in millions of US dollars except as otherwise noted

Condensed Consolidated Statements of Earnings

		Three Months Ended				Six Months Ended
		June 30				June 30
	Note	2021		2020		2021		2020
				Note 1				Note 1
SALES	2	9,763		8,431		14,421		12,629
Freight, transportation and distribution		222		237		433		449
Cost of goods sold		6,659		6,024		9,950		9,125
GROSS MARGIN		2,882		2,170		4,038		3,055
Selling expenses		865		763		1,538		1,405
General and administrative expenses		116		101		219		205
Provincial mining taxes		107		48		165		105
Share-based compensation expense (recovery)		38		12		61		(20)
Other expenses	3	137		107		158		139
EARNINGS BEFORE FINANCE COSTS AND INCOME TAXES		1,619		1,139		1,897		1,221
Finance costs		125		139		245		272
EARNINGS BEFORE INCOME TAXES		1,494		1,000		1,652		949
Income tax expense	4	381		235		406		219
NET EARNINGS		1,113		765		1,246		730
Attributable to
Equity holders of Nutrien		1,108		765		1,235		730
Non-controlling interest		5		-		11		-
NET EARNINGS		1,113		765		1,246		730
NET EARNINGS PER SHARE ATTRIBUTABLE TO EQUITY HOLDERS OF NUTRIEN ("EPS")
Basic		1.94		1.34		2.17		1.28
Diluted		1.94		1.34		2.16		1.28
Weighted average shares outstanding for basic EPS		570,352,000		569,146,000		570,007,000		570,157,000
Weighted average shares outstanding for diluted EPS		571,972,000		569,146,000		571,453,000		570,157,000

Condensed Consolidated Statements of Comprehensive Income

	Three Months Ended				Six Months Ended
	June 30				June 30
(Net of related income taxes)	2021		2020		2021		2020
NET EARNINGS	1,113		765		1,246		730
Other comprehensive income (loss)
Items that will not be reclassified to net earnings:
Net actuarial gain on defined benefit plans	-		-		-		3
Net fair value gain (loss) on investments	22		(2)		70		(21)
Items that have been or may be subsequently reclassified to
net earnings:
Gain (loss) on currency translation of foreign operations	25		194		(5)		(121)
Other	14		9		20		(18)
OTHER COMPREHENSIVE INCOME (LOSS)	61		201		85		(157)
COMPREHENSIVE INCOME	1,174		966		1,331		573
Attributable to
Equity holders of Nutrien	1,170		966		1,321		573
Non-controlling interest	4		-		10		-
COMPREHENSIVE INCOME	1,174		966		1,331		573
(See Notes to the Condensed Consolidated Financial Statements)

Condensed Consolidated Statements of Cash Flows

		Three Months Ended				Six Months Ended
		June 30				June 30
	Note	2021		2020		2021		2020
OPERATING ACTIVITIES
Net earnings		1,113		765		1,246		730
Adjustments for:
Depreciation and amortization		485		517		965		990
Share-based compensation expense (recovery)		38		12		61		(20)
Impairment of assets		1		-		5		-
(Recovery of) provision for deferred income tax		(20)		84		(10)		62
Cloud computing transition adjustment	3	36		-		36		-
Other long-term assets, liabilities and miscellaneous		64		(60)		54		(100)
Cash from operations before working capital changes		1,717		1,318		2,357		1,662
Changes in non-cash operating working capital:
Receivables		(2,443)		(1,824)		(2,835)		(2,147)
Inventories		1,848		2,174		63		746
Prepaid expenses and other current assets		310		247		998		1,013
Payables and accrued charges		534		(159)		1,231		(44)
CASH PROVIDED BY OPERATING ACTIVITIES		1,966		1,756		1,814		1,230
INVESTING ACTIVITIES
Additions to property, plant and equipment		(378)		(298)		(703)		(661)
Additions to intangible assets		(5)		(36)		(38)		(68)
Business acquisitions, net of cash acquired		(19)		(116)		(40)		(173)
Other		(29)		42		(38)		49
CASH USED IN INVESTING ACTIVITIES		(431)		(408)		(819)		(853)
FINANCING ACTIVITIES
Transaction costs related to debt		(7)		(15)		(7)		(15)
(Repayment of) proceeds from short-term debt, net		(104)		(4,290)		(3)		204
Proceeds from long-term debt		8		1,500		8		1,506
Repayment of long-term debt		(5)		(6)		(5)		(507)
Repayment of principal portion of lease liabilities		(86)		(70)		(164)		(134)
Dividends paid to Nutrien's shareholders	6	(263)		(258)		(518)		(514)
Repurchase of common shares	6	(1)		-		(2)		(160)
Issuance of common shares		21		-		63		-
Other		(12)		-		(12)		-
CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES		(449)		(3,139)		(640)		380
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS		(4)		24		(15)		(13)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		1,082		(1,767)		340		744
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD		712		3,182		1,454		671
CASH AND CASH EQUIVALENTS - END OF PERIOD		1,794		1,415		1,794		1,415
Cash and cash equivalents comprised of:
Cash		1,580		1,106		1,580		1,106
Short-term investments		214		309		214		309
		1,794		1,415		1,794		1,415
SUPPLEMENTAL CASH FLOWS INFORMATION
Interest paid		86		153		162		249
Income taxes paid		105		30		144		65
Total cash outflow for leases		111		96		208		188
(See Notes to the Condensed Consolidated Financial Statements)

Condensed Consolidated Statements of Changes in Shareholders' Equity

							Accumulated Other Comprehensive (Loss) Income ("AOCI")
									Net
									Actuarial		Loss on								Equity
						Net Fair Value			Gain on		Currency								Holders		Non-
	Number of						(Loss) Gain		Defined		Translation								of		Controlling
	Common		Share	Contributed			on		Benefit		of Foreign				Total		Retained		Nutrien		Interest		Total
	Shares		Capital		Surplus		Investments		Plans 1		Operations		Other		AOCI		Earnings		(Note 1)		(Note 1)		Equity
BALANCE - DECEMBER 31, 2019	572,942,809		15,771		248		(29)		-		(204)		(18)		(251)		7,101		22,869		38		22,907
Net earnings	-		-		-		-		-		-		-		-		730		730		-		730
Other comprehensive (loss) income	-		-		-		(21)		3		(121)		(18)		(157)		-		(157)		-		(157)
Shares repurchased (Note 6)	(3,832,580)		(105)		(55)		-		-		-		-		-		-		(160)		-		(160)
Dividends declared	-		-		-		-		-		-		-		-		(514)		(514)		-		(514)
Effect of share-based
compensation including
issuance of common shares	35,706		1		7		-		-		-		-		-		-		8		-		8
Transfer of net loss on
cash flow hedges	-		-		-		-		-		-		11		11		-		11		-		11
Transfer of net actuarial gain
on defined benefit plans	-		-		-		-		(3)		-		-		(3)		3		-		-		-
BALANCE - JUNE 30, 2020	569,145,935		15,667		200		(50)		-		(325)		(25)		(400)		7,320		22,787		38		22,825
BALANCE - DECEMBER 31, 2020	569,260,406		15,673		205		(36)		-		(62)		(21)		(119)		6,606		22,365		38		22,403
Net earnings	-		-		-		-		-		-		-		-		1,235		1,235		11		1,246
Other comprehensive income (loss)	-		-		-		70		-		(4)		20		86		-		86		(1)		85
Shares repurchased (Note 6)	(32,728)		(1)		(1)		-		-		-		-		-		-		(2)		-		(2)
Dividends declared	-		-		-		-		-		-		-		-		(526)		(526)		-		(526)
Non-controlling interest transactions	-		-		-		-		-		-		-		-		-		-		(12)		(12)
Effect of share-based
compensation including
issuance of common shares	-		74		(3)		-		-		-		-		-		-		71		-		71
Transfer of net gain on cash flow hedges	-		-		-		-		-		-		(11)		(11)		-		(11)		-		(11)
BALANCE - JUNE 30, 2021	569,227,678		15,746		201		34		-		(66)		(12)		(44)		7,315		23,218		36		23,254
1 Any amounts incurred during a period were transferred to retained earnings at each period-end. Therefore, no balance exists at the beginning or end of period.
(See Notes to the Condensed Consolidated Financial Statements)

Condensed Consolidated Balance Sheets

		June 30				December 31
As at	Note	2021		2020		2020
				Note 1		Note 1
ASSETS
Current assets
Cash and cash equivalents		1,794		1,415		1,454
Receivables		6,683		5,736		3,626
Inventories		4,876		4,199		4,930
Prepaid expenses and other current assets		524		420		1,460
		13,877		11,770		11,470
Non-current assets
Property, plant and equipment		19,592		20,178		19,660
Goodwill		12,211		12,096		12,198
Other intangible assets		2,393		2,376		2,388
Investments		619		803		562
Other assets		664		578		914
TOTAL ASSETS		49,356		47,801		47,192
LIABILITIES
Current liabilities
Short-term debt		210		1,247		159
Current portion of long-term debt		32		-		14
Current portion of lease liabilities		276		228		249
Payables and accrued charges		9,367		7,306		8,058
		9,885		8,781		8,480
Non-current liabilities
Long-term debt		10,029		10,032		10,047
Lease liabilities		900		841		891
Deferred income tax liabilities	4	3,118		3,212		3,149
Pension and other post-retirement benefit liabilities		458		435		454
Asset retirement obligations and accrued environmental costs		1,559		1,575		1,597
Other non-current liabilities		153		100		171
TOTAL LIABILITIES		26,102		24,976		24,789
SHAREHOLDERS' EQUITY
Share capital	6	15,746		15,667		15,673
Contributed surplus		201		200		205
Accumulated other comprehensive loss		(44)		(400)		(119)
Retained earnings		7,315		7,320		6,606
Equity holders of Nutrien		23,218		22,787		22,365
Non-controlling interest		36		38		38
TOTAL SHAREHOLDERS' EQUITY		23,254		22,825		22,403
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY		49,356		47,801		47,192
(See Notes to the Condensed Consolidated Financial Statements)

Notes to the Condensed Consolidated Financial Statements

As at and for the Three and Six Months Ended June 30, 2021

NOTE 1 BASIS OF PRESENTATION

Nutrien Ltd. (collectively with its subsidiaries, known as "Nutrien", "we", "us", "our" or "the Company") is the world's largest provider of crop inputs and services. Nutrien plays a critical role in helping growers around the globe increase food production in a sustainable manner.

These unaudited interim condensed consolidated financial statements ("interim financial statements") are based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and have been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting". The accounting policies and methods of computation used in preparing these interim financial statements are consistent with those used in the preparation of our 2020 annual consolidated financial statements except as disclosed in Note 3. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual consolidated financial statements and should be read in conjunction with our 2020 annual consolidated financial statements.

Certain immaterial 2020 figures have been reclassified in the condensed consolidated statements of earnings, condensed consolidated statements of changes in shareholders' equity, condensed consolidated balance sheets and segment information.

In management's opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year.

We prepare our interim financial statements in accordance with IFRS, which requires us to make judgments, assumptions and estimates in applying accounting policies. We have assessed our accounting estimates and other matters that require the use of forecasted financial information for the impacts arising from the novel coronavirus ("COVID-19") pandemic. The future assessment of these estimates, including expectations about the severity, duration and scope of the pandemic, could differ materially in future reporting periods. As a result of the COVID-19 pandemic, we incurred directly attributable and incremental COVID-19 related expenses in other expenses (Note 3).

These interim financial statements were authorized by the audit committee of the Board of Directors for issue on August 9, 2021.

NOTE 2 SEGMENT INFORMATION

The Company has four reportable operating segments: Nutrien Ag Solutions ("Retail"), Potash, Nitrogen and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and it provides services directly to growers through a network of farm centers in North America, South America and Australia. The Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each produce.

		Three Months Ended June 30, 2021
										Corporate
		Retail		Potash		Nitrogen		Phosphate		and Others		Eliminations		Consolidated
Sales	- third party	7,522		844		1,008		389		-		-		9,763
	- intersegment	15		61		307		60		-		(443)		-
Sales	- total	7,537		905		1,315		449		-		(443)		9,763
Freight, transportation and distribution		-		88		136		46		-		(48)		222
Net sales		7,537		817		1,179		403		-		(395)		9,541
Cost of goods sold		5,679		317		763		319		-		(419)		6,659
Gross margin		1,858		500		416		84		-		24		2,882
Selling expenses		863		2		8		1		(9)		-		865
General and administrative expenses		41		3		3		3		66		-		116
Provincial mining taxes		-		107		-		-		-		-		107
Share-based compensation expense		-		-		-		-		38		-		38
Other expenses		34		11		6		3		83		-		137
Earnings (loss) before finance costs and
income taxes		920		377		399		77		(178)		24		1,619
Depreciation and amortization		169		116		155		35		10		-		485
EBITDA		1,089		493		554		112		(168)		24		2,104
Integration and restructuring related costs		7		-		-		-		22		-		29
Share-based compensation expense		-		-		-		-		38		-		38
Impairment of assets		-		-		1		-		-		-		1
COVID-19 related expenses		-		-		-		-		9		-		9
Foreign exchange gain, net of
related derivatives		-		-		-		-		(2)		-		(2)
Cloud computing transition adjustment		1		2		-		-		33		-		36
Adjusted EBITDA		1,097		495		555		112		(68)		24		2,215
Assets - at June 30, 2021		21,784		12,107		10,266		1,454		4,414		(669)		49,356

		Three Months Ended June 30, 2020
										Corporate
		Retail		Potash		Nitrogen		Phosphate		and Others		Eliminations		Consolidated
Sales	- third party	6,754		617		755		285		20		-		8,431
	- intersegment	10		64		246		49		-		(369)		-
Sales	- total	6,764		681		1,001		334		20		(369)		8,431
Freight, transportation and distribution		-		93		148		57		-		(61)		237
Net sales		6,764		588		853		277		20		(308)		8,194
Cost of goods sold		5,137		310		645		249		18		(335)		6,024
Gross margin		1,627		278		208		28		2		27		2,170
Selling expenses		764		1		5		1		(8)		-		763
General and administrative expenses		30		1		2		3		65		-		101
Provincial mining taxes		-		46		1		-		1		-		48
Share-based compensation expense		-		-		-		-		12		-		12
Other expenses (income)		32		4		(11)		3		79		-		107
Earnings (loss) before finance costs and
income taxes		801		226		211		21		(147)		27		1,139
Depreciation and amortization		163		109		172		56		17		-		517
EBITDA		964		335		383		77		(130)		27		1,656
Integration and restructuring related costs		-		-		-		-		18		-		18
Share-based compensation expense		-		-		-		-		12		-		12
COVID-19 related expenses		-		-		-		-		17		-		17
Foreign exchange loss, net of
related derivatives		-		-		-		-		18		-		18
Adjusted EBITDA		964		335		383		77		(65)		27		1,721
Assets - at December 31, 2020 ¹		20,526		11,707		10,077		1,388		3,917		(423)		47,192
1 In 2021, certain assets related to transportation, distribution and logistics were reclassified under Corporate and Others as these are centrally managed. Comparative figures have been restated to reflect this change. Depreciation expense related to these assets are allocated to the rest of the segments based on usage.

		Six Months Ended June 30, 2021
										Corporate
		Retail		Potash		Nitrogen		Phosphate		and Others		Eliminations		Consolidated
Sales	- third party	10,482		1,475		1,703		761		-		-		14,421
	- intersegment	27		151		467		132		-		(777)		-
Sales	- total	10,509		1,626		2,170		893		-		(777)		14,421
Freight, transportation and distribution		-		198		231		105		-		(101)		433
Net sales		10,509		1,428		1,939		788		-		(676)		13,988
Cost of goods sold		7,999		608		1,373		638		-		(668)		9,950
Gross margin		2,510		820		566		150		-		(8)		4,038
Selling expenses		1,530		5		15		3		(15)		-		1,538
General and administrative expenses		80		5		5		5		124		-		219
Provincial mining taxes		-		165		-		-		-		-		165
Share-based compensation expense		-		-		-		-		61		-		61
Other expenses (income)		49		12		(20)		6		111		-		158
Earnings (loss) before finance costs and
income taxes		851		633		566		136		(281)		(8)		1,897
Depreciation and amortization		346		240		284		73		22		-		965
EBITDA		1,197		873		850		209		(259)		(8)		2,862
Integration and restructuring related costs		8		-		-		-		31		-		39
Share-based compensation expense		-		-		-		-		61		-		61
Impairment of assets		-		-		5		-		-		-		5
COVID-19 related expenses		-		-		-		-		18		-		18
Cloud computing transition adjustment		1		2		-		-		33		-		36
Adjusted EBITDA		1,206		875		855		209		(116)		(8)		3,021
Assets - at June 30, 2021		21,784		12,107		10,266		1,454		4,414		(669)		49,356

		Six Months Ended June 30, 2020
										Corporate
		Retail		Potash		Nitrogen		Phosphate		and Others		Eliminations		Consolidated
Sales	- third party	9,406		1,164		1,401		611		47		-		12,629
	- intersegment	19		128		378		106		-		(631)		-
Sales	- total	9,425		1,292		1,779		717		47		(631)		12,629
Freight, transportation and distribution		-		187		248		127		-		(113)		449
Net sales		9,425		1,105		1,531		590		47		(518)		12,180
Cost of goods sold		7,257		575		1,226		569		43		(545)		9,125
Gross margin		2,168		530		305		21		4		27		3,055
Selling expenses		1,399		4		12		3		(13)		-		1,405
General and administrative expenses		68		3		4		5		125		-		205
Provincial mining taxes		-		103		1		-		1		-		105
Share-based compensation recovery		-		-		-		-		(20)		-		(20)
Other expenses (income)		48		5		(9)		9		86		-		139
Earnings (loss) before finance costs and
income taxes		653		415		297		4		(175)		27		1,221
Depreciation and amortization		318		205		322		119		26		-		990
EBITDA		971		620		619		123		(149)		27		2,211
Integration and restructuring related costs		-		-		-		-		28		-		28
Share-based compensation recovery		-		-		-		-		(20)		-		(20)
COVID-19 related expenses		-		-		-		-		19		-		19
Foreign exchange gain, net of
related derivatives		-		-		-		-		(9)		-		(9)
Adjusted EBITDA		971		620		619		123		(131)		27		2,229
Assets - at December 31, 2020		20,526		11,707		10,077		1,388		3,917		(423)		47,192

Presented below is revenue from contracts with customers disaggregated by product line or geographic location for each reportable segment.

	Three Months Ended				Six Months Ended
	June 30				June 30
	2021		2020		2021		2020
Retail sales by product line
Crop nutrients	3,045		2,527		4,061		3,312
Crop protection products	2,666		2,436		3,751		3,446
Seed	1,216		1,141		1,679		1,535
Merchandise	268		253		498		469
Nutrien Financial	59		40		84		56
Services and other	335		400		508		655
Nutrien Financial elimination 1	(52)		(33)		(72)		(48)
	7,537		6,764		10,509		9,425
Potash sales by geography
Manufactured product
North America	414		325		856		644
Offshore 2	491		356		770		648
	905		681		1,626		1,292
Nitrogen sales by product line
Manufactured product
Ammonia	405		291		593		447
Urea	372		304		646		566
Solutions, nitrates and sulfates	329		233		526		429
Other nitrogen and purchased products	209		173		405		337
	1,315		1,001		2,170		1,779
Phosphate sales by product line
Manufactured product
Fertilizer	258		185		530		406
Industrial and feed	133		117		259		237
Other phosphate and purchased products	58		32		104		74
	449		334		893		717
1 Represents elimination for the interest and service fees charged by Nutrien Financial to Retail branches.
2 Relates to Canpotex Limited ("Canpotex") (Note 8).

NOTE 3 OTHER (INCOME) EXPENSES

	Three Months Ended				Six Months Ended
	June 30				June 30
	2021		2020		2021		2020
Integration and restructuring related costs	29		18		39		28
Foreign exchange loss (gain), net of related derivatives	1		18		3		(13)
Earnings of equity-accounted investees	(2)		(13)		(22)		(23)
Bad debt expense	13		21		15		27
COVID-19 related expenses	9		17		18		19
Impairment of assets	1		-		5		-
Cloud computing transition adjustment	36		-		36		-
Other expenses	50		46		64		101
	137		107		158		139

In April 2021, the IFRS Interpretations Committee published a final agenda decision clarifying how to recognize certain configuration and customization expenditures related to cloud computing with retrospective application. Costs that do not meet the capitalization criteria should be expensed as incurred. We changed our accounting policy to align with the interpretation and previously capitalized costs that no longer qualify for capitalization were expensed in the current period since they were not material.

NOTE 4 INCOME TAXES

A separate estimated average annual effective income tax rate was determined for each taxing jurisdiction and applied individually to the interim period pre-tax earnings for each jurisdiction.

	Three Months Ended				Six Months Ended
	June 30				June 30
	2021		2020		2021		2020
Income tax expense	381		235		406		219
Actual effective tax rate on earnings (%)	26		25		25		24
Actual effective tax rate including discrete items (%)	26		24		25		23
Discrete tax adjustments that impacted the tax rate	(3)		(13)		(3)		(11)

Income tax balances within the condensed consolidated balance sheets were comprised of the following:

Income Tax Assets and Liabilities	Balance Sheet Location	As at June 30, 2021		As at December 31, 2020
Income tax assets
Current	Receivables	346		83
Non-current	Other assets	89		305
Deferred income tax assets	Other assets	221		242
Total income tax assets		656		630
Income tax liabilities
Current	Payables and accrued charges	335		48
Non-current	Other non-current liabilities	49		40
Deferred income tax liabilities	Deferred income tax liabilities	3,118		3,149
Total income tax liabilities		3,502		3,237

NOTE 5 FINANCIAL INSTRUMENTS

Fair Value

Estimated fair values for financial instruments are designed to approximate amounts for which the instruments could be exchanged in a current arm's-length transaction between knowledgeable, willing parties. The valuation policies and procedures for financial reporting purposes are determined by our finance department. There have been no changes to our valuation methods presented in Note 10 of the 2020 annual consolidated financial statements and those valuation methods have been applied in these interim financial statements.

The following table presents our fair value hierarchy for financial instruments carried at fair value on a recurring basis or measured at amortized cost:

	June 30, 2021								December 31, 2020
	Carrying								Carrying
Financial assets (liabilities) measured at	Amount		Level 1 1		Level 2 1		Level 3		Amount		Level 1 1		Level 2 1
Fair value on a recurring basis
Cash and cash equivalents	1,794		-		1,794		-		1,454		-		1,454
Derivative instrument assets	27		-		27		-		45		-		45
Other current financial assets
- marketable securities 2	224		31		193		-		161		24		137
Investments at FVTOCI 3	233		223		-		10		153		153		-
Derivative instrument liabilities	(20)		-		(20)		-		(48)		-		(48)
Amortized cost
Current portion of long-term debt
Fixed and floating rate debt	(32)		-		(32)		-		(14)		-		(14)
Long-term debt
Notes and debentures	(9,988)		(7,763)		(3,721)		-		(9,994)		(3,801)		(7,955)
Fixed and floating rate debt	(41)		-		(41)		-		(53)		-		(53)
1 During the periods ended June 30, 2021 and December 31, 2020, there were no transfers between Level 1 and Level 2 for financial instruments measured at fair value on a recurring basis.
2 Marketable securities consist of equity and fixed income securities. We determine the fair value of equity securities based on the bid price of identical instruments in active markets. We value fixed income securities using quoted prices of instruments with similar terms and credit risk.
3 Investments at fair value through other comprehensive income ("FVTOCI") is primarily comprised of shares in Sinofert Holdings Ltd.

NOTE 6 SHARE CAPITAL

Share repurchase programs

					Maximum		Maximum		Number of
	Commencement				Shares for		Shares for		Shares
	Date		Expiry		Repurchase		Repurchase (%)		Repurchased
2019 Normal Course Issuer Bid	February 27, 2019		February 26, 2020		42,164,420		7		33,256,668
2020 Normal Course Issuer Bid	February 27, 2020		February 26, 2021		28,572,458		5		710,100
2021 Normal Course Issuer Bid 1	March 1, 2021		February 28, 2022		28,468,448		5		32,728
1 The 2021 normal course issuer bid will expire earlier than the date above if we acquire the maximum number of common shares allowable or otherwise decide not to make any further repurchases.

Purchases under the normal course issuer bids were, or may be, made through open market purchases at market prices as well as by other means permitted by applicable securities regulatory authorities, including private agreements.

The following table summarizes our share repurchase activities during the period:

	Three Months Ended				Six Months Ended
	June 30				June 30
	2021		2020		2021		2020
Number of common shares repurchased for cancellation	17,750		-		32,728		3,832,580
Average price per share (US dollars)	52.88		-		52.90		41.96
Total cost	1		-		2		160

Dividends declared

We declared a dividend per share of $0.46 (2020 - $0.45) during the three months ended June 30, 2021, payable on July 16, 2021 to shareholders of record on June 30, 2021 and total dividends of $0.92 (2020 - $0.90) during the six months ended June 30, 2021.

NOTE 7 SEASONALITY

Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. The results of this seasonality have a corresponding effect on receivables from customers and rebates receivables, inventories, prepaid expenses and other current assets and trade payables. Our short-term debt also fluctuates during the year to meet working capital needs. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

NOTE 8 RELATED PARTY TRANSACTIONS

We sell potash outside Canada and the United States exclusively through Canpotex. Canpotex sells potash to buyers in export markets pursuant to term and spot contracts at agreed upon prices. Our revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. Sales to Canpotex are shown in Note 2.

As at	June 30, 2021		December 31, 2020
Receivables from Canpotex	356		122

View source version on businesswire.com: https://www.businesswire.com/news/home/20210809005791/en/

Contact

Investor Relations:
Richard Downey
Vice President, Investor Relations
(403) 225-7357
Investors@nutrien.com

Tim Mizuno
Director, Investor Relations
(306) 933-8548

Media Relations:
Megan Fielding
Vice President, Brand & Culture Communications
(403) 797-3015

Contact us at: www.nutrien.com